🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
613 medicines starting with “T”
MedicineActive substanceLicence holderStatus
Temomedac 20 mg hard capsules
EU/1/09/605/3-4
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 250 mg hard capsules
EU/1/09/605/11-12
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 5 mg hard capsules
EU/1/09/605/1-2
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temozolomide Accord 100 mg hard capsules
EU/1/10/615/009-010
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 140 mg hard capsules
EU/1/10/615/013-014
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 180 mg hard capsules
EU/1/10/615/017-018
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 20 mg hard capsules
EU/1/10/615/005-006
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 250 mg hard capsules
EU/1/10/615/021-022
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 5 mg hard capsules
EU/1/10/615/001-002
Temozolomide Accord Healthcare S.L.U.
Temozolomide Clonmel 100mg hard capsules
PA0126/188/003
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 140mg hard capsules
PA0126/188/004
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 180 mg hard capsules
PA0126/188/005
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 20 mg hard capsules
PA0126/188/002
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 250 mg hard capsules
PA0126/188/006
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 5mg hard capsules
PA0126/188/001
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide FAIR-MED 100 mg hard capsules
PA23270/002/003
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 140 mg hard capsules
PA23270/002/004
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 180 mg hard capsules
PA23270/002/005
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 20 mg hard capsules
PA23270/002/002
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 250 mg hard capsules
PA23270/002/006
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 5 mg hard capsules
PA23270/002/001
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide Teva 100 mg hard capsules
EU/1/09/606/005-006
Temozolomide Teva B.V.
Temozolomide Teva 140 mg hard capsules
EU/1/09/606/007-008
Temozolomide Teva B.V.
Temozolomide Teva 180 mg hard capsules
EU/1/09/606/009-010
Temozolomide Teva B.V.
Temozolomide Teva 20 mg hard capsules
EU/1/09/606/003-004
Temozolomide Teva B.V.
Temozolomide Teva 250 mg hard capsules
EU/1/09/606/011-012
Temozolomide Teva B.V.
Temozolomide Teva 5 mg hard capsules
EU/1/09/606/001-002
Temozolomide Teva B.V.
Tendrotil SR 2 mg Prolonged-Release Capsules, Hard
PA2315/134/001
Tolterodine tartrate Accord Healthcare Ireland Ltd. Marketed
Tendrotil SR 4 mg Prolonged-Release Capsules, Hard
PA2315/134/002
Tolterodine tartrate Accord Healthcare Ireland Ltd. Marketed
Tenkasi 1200 mg powder for concentrate for solution for infusion
EU/1/15/989/002
Oritavancin Menarini International Operations Luxembourg S.A.
Tenkasi 400 mg powder for concentrate for solution for infusion
EU/1/15/989/001
Oritavancin Menarini International Operations Luxembourg S.A.
Tenofovir Disoproxil Teva 245 mg film-coated tablets
PA1986/003/001
Tenofovir disoproxil Teva B.V. Marketed
Tenofovir disoproxil Viatris 245 mg film-coated tablets
EU/1/16/1129/001
Tenofovir disoproxil Viatris Limited
Tenofovir disoproxil Zentiva 245 mg film-coated tablets
EU/1/16/1127/001-002
Tenofovir disoproxil phosphate Zentiva k.s.
TEPADINA 100 mg powder for concentrate for solution for infusion
EU/1/10/622/002
Thiotepa Adienne S.r.l.
TEPADINA 15 mg powder for concentrate for solution for infusion
EU/1/10/622/001
Thiotepa Adienne S.r.l.
TEPADINA 200 mg powder and solvent for solution for infusion
EU/1/10/622/004
Thiotepa Adienne S.r.l. S.U.
TEPADINA 400 mg powder and solvent for solution for infusion
EU/1/10/622/003
Thiotepa Adienne S.r.l. S.U.
TEPEZZA 500 mg powder for concentrate for solution for infusion
EU/1/25/1941/001
Teprotumumab Amgen Europe B.V.,
Tepkinly 4 mg/0.8 ml solution for injection
EU/1/23/1759/001
Epcoritamab AbbVie Deutschland GmbH & Co. KG
Tepkinly 48 mg solution for injection
EU/1/23/1759/002
Epcoritamab AbbVie Deutschland GmbH & Co. KG
TEPMETKO 225 mg film-coated tablets
EU/1/21/1596/001
Tepotinib hydrochloride monohydrate Merck Europe B.V.
Terbasil 250 mg tablets
PA2315/099/001
Terbinafine Accord Healthcare Ireland Ltd. Marketed
Terbinafine Rowa 250 mg tablets
PA0074/084/001
Terbinafine Rowa Pharmaceuticals Limited Marketed
Terbza 98 mg/ml cutaneous solution
PA23368/001/001
Terbinafine hydrochloride Moberg Pharma AB (publ) Not marketed
Teriflunomide Accord 14 mg film-coated tablets
EU/1/22/1693/001-004
Teriflunomide Accord Healthcare S.L.U.
Teriflunomide Accord 7 mg film-coated tablets
EU/1/22/1693/005-012
Teriflunomide Accord Healthcare S.L.U.
Teriflunomide Clonmel 14 mg film-coated tablets
PA0126/375/001
Teriflunomide Clonmel Healthcare Ltd Marketed
Teriflunomide Viatris 14 mg film-coated tablets
EU/1/22/1698/001-007
Teriflunomide Mylan Pharmaceuticals Limited
Teriparatide SUN 20 micrograms/80 microliters solution for injection in pre-filled pen
EU/1/22/1697/001-002
Teriparatide Sun Phamaceutical Industries Europe B.V.
2 3 4 5 6 7 8

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.